Structural Formula (Fen04 0006 01)
Fentanyl System Patch
Product Images NDC 47781-427
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Fentanyl System (NDC 47781-427). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Alvogen, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Fen04 0006 02)
This appears to be a description of a pharmaceutical product with a "drug containing layer" sandwiched between a "release liner" and a "backing layer". The purpose of the release liner and backing layer are unclear without additional context.*
Figure 1 (Fen04 0006 03)
The text is describing the concentration of Fentanyl measured in ng/mL using two different systems: TonsdemrlSyscem and Tansdemt Sytem. The measurements were taken using 100 meoh and 100 mepm solutions. However, it is not clear what the numbers 1, 130, 3, and 4, 34 indicate.*
Parts Of The Fentanyl Transdermal System Patch (Fen04 0006 04)
This appears to be the description of a three-layered medical patch or device. The first layer is a "protective liner" which protects the drug-containing portion from damage or contamination during packaging or handling. The second layer is the "drug containing layer" and likely contains a medication or active ingredient which is meant to be delivered to the skin. The final layer is the "backing layer" which helps to attach the patch to the skin and ensure the medication is absorbed effectively.*
Figure A (Fen04 0006 05)
Figure B (Fen04 0006 06)
Figure C (Fen04 0006 07)
Figure D (Fen04 0006 08)
Figure E (Fen04 0006 09)
Figure F (Fen04 0006 10)
Figure G (Fen04 0006 11)
Figure H (Fen04 0006 12)
Figure I (Fen04 0006 13)
Figure J (Fen04 0006 14)
Principal Display Panel (12 mcg/h Patch Carton)
This is information on a Fentanyl Transdermal System. The usual dosage should be determined based on accompanying product literature. The product contains 1.3mg of fentanyl and is delivered at a rate of 12mcg/hour for 72 hours. The system should be applied immediately after removal from the protective liner with no exposure to heat. The product should not be used for pain that can be treated with immediate-release opioids, nonopioid analgesics, or intermittent pain. The system should be stored in its original unopened pouch and out of reach of children. More information is available in the enclosed Medication Guide. For questions or a medical emergency, contact Alvogen at 1-866-770-3024.*
Principal Display Panel (25 mcg/h Patch Carton)
This is a description of a Fentanyl Transdermal System, which delivers 25 mcg/h of fentanyl in vivo for 72 hours. Each system contains 2.6 mg of fentanyl, and the inactive ingredients include acrilate copolymer adhesive, methyl/laurate, 3M Scotchpak 9732 backing, and 3M Scotchpak 9744. The transdermal system should not be used for pain that can be treated with immediate-release opioids or non-opioid analgesics, for intermittent pain, or for postoperative pain, unless the patient is opioid tolerant. The medication guide should be read for important safety information. The system should be stored in its original unopened pouch at up to 25°C (77°F) with excursions permitted to 15 to 30°C (59 to 86°F), and should be kept out of reach of children. For medical emergencies, 911 should be called, and for questions about the product, Alvogen can be contacted at 1-866-770-3024.*
Principal Display Panel (50 mcg/h Patch Carton)
FENTANYL Transdermal System is a medication patch that delivers fentanyl transdermal. Each patch contains 5.32 mg fentanyl for 72 hours of use. It is important not to use this system for pain that can be treated with non-opioid medication, for intermittent pain, or for any postoperative pain unless you have been using other narcotic opioid medications. If the seal on the patch pouch is broken, do not use it. It should be stored at room temperature, and kept away from heat sources. In case of medical emergency, call 911. For further questions, contact Alvogen at 1-866-770-3024.*
Principal Display Panel (75 mcg/h Patch Carton)
This is a description of a medication called Fentanyl Transdermal System. It delivers 75mcg of Fentanyl in vivo for 72 hours, and includes instructions to not use it for non-opioid or as-needed pain, or if the patient is not already tolerant to opioids. The product comes in an unopened pouch and has specific dosage instructions. Inactive ingredients include acrylate copolymer adhesive and two types of Scotchpak backings. For more information on this product, the patient is advised to read the enclosed Medication Guide. Contact information for Alvogen, the manufacturer, is also provided if there are any questions or concerns. Some important safety information is also referenced.*
Principal Display Panel (100 mcg/h Patch Carton)
FENTANYL Transdermal System is a transdermal patch containing 100 mcg/h of fentanyl, an opioid medication used for severe chronic pain. Each patch contains 10.65 mg of fentanyl, and is designed to be applied immediately after removal from the pouch and removal of the protective liner. The patch must not be exposed to external heat and is to be stored in the original unopened pouch at temperatures up to 25°C. The patch is not to be used for pain that can be treated with immediate-release opioids or non-opioid analgesics, intermittent pain or after any postoperative pain unless you are opioid tolerant. The patch has the potential to cause serious or life-threatening breathing problems, so caution must be exercised while using it. It is vital to keep the patch out of the reach of children, and the enclosed Medication Guide must be read for critical safety information.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
